retatrutide ly3437943 triple agonist glp-1 gip glucagon LY3437943, a novel glucagon, GIP, and receptor for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Retatrutide is a triple-agonist drug
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


00226-8/asset/34cd96f1-6db7-4717-834c-4ef722d58de8/main.assets/gr3_lrg.jpg)






















